Lv41
460 积分 2023-10-10 加入
Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway
37分钟前
已完结
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment
44分钟前
已完结
Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System
2小时前
已完结
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview
4天前
已完结
Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab
1个月前
已完结
QC Assay Development
1个月前
已完结
Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer Immunotherapy
1个月前
已完结
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
1个月前
已完结
Homogeneous Dual-Payload Antibody-Drug Conjugates Produced by Combined Distinct Conjugation Strategies
1个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
1个月前
已完结
皖公网安备34019202002308
